| Irfan Fazil, MD | |
|
11518 N Frontage Rd, Yuma, AZ 85367-8994 | |
| (928) 342-6500 | |
| Not Available |
| Full Name | Irfan Fazil |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 11518 N Frontage Rd, Yuma, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528018819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 35023 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bio Family Clinic Inc | 2769668136 | 24 |
News Archive
Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
Results from a new study indicate that older hospitalized patients with cancer may have a high risk of being malnourished and experiencing symptoms such as no appetite and nausea, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A quality-improvement project to standardize feeding practices for micro preemies-preterm infants born months before their due date- helped to boost their weight and nearly quadrupled the frequency of lactation consultations ordered in the neonatal intensive care unit, a multidisciplinary team from Children's National Health System finds.
› Verified 3 days ago
| Entity Name | Bio Family Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821387051 PECOS PAC ID: 2769668136 Enrollment ID: O20110519000360 |
News Archive
Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
Results from a new study indicate that older hospitalized patients with cancer may have a high risk of being malnourished and experiencing symptoms such as no appetite and nausea, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A quality-improvement project to standardize feeding practices for micro preemies-preterm infants born months before their due date- helped to boost their weight and nearly quadrupled the frequency of lactation consultations ordered in the neonatal intensive care unit, a multidisciplinary team from Children's National Health System finds.
› Verified 3 days ago
| Entity Name | Bio Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033643374 PECOS PAC ID: 2062780018 Enrollment ID: O20170614002709 |
News Archive
Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
Results from a new study indicate that older hospitalized patients with cancer may have a high risk of being malnourished and experiencing symptoms such as no appetite and nausea, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A quality-improvement project to standardize feeding practices for micro preemies-preterm infants born months before their due date- helped to boost their weight and nearly quadrupled the frequency of lactation consultations ordered in the neonatal intensive care unit, a multidisciplinary team from Children's National Health System finds.
› Verified 3 days ago
| Entity Name | Yuma Kidney & Dialysis Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295229672 PECOS PAC ID: 7315298502 Enrollment ID: O20180927001213 |
News Archive
Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
Results from a new study indicate that older hospitalized patients with cancer may have a high risk of being malnourished and experiencing symptoms such as no appetite and nausea, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A quality-improvement project to standardize feeding practices for micro preemies-preterm infants born months before their due date- helped to boost their weight and nearly quadrupled the frequency of lactation consultations ordered in the neonatal intensive care unit, a multidisciplinary team from Children's National Health System finds.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Irfan Fazil, MD Po Box 669, Yuma, AZ 85366-2329 Ph: (928) 342-6500 | Irfan Fazil, MD 11518 N Frontage Rd, Yuma, AZ 85367-8994 Ph: (928) 342-6500 |
News Archive
Sanofi-aventis announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus (insulin glargine [rDNA origin] injection) once-daily and Apidra (insulin glulisine [rDNA origin] injection) before meals improved glycemic control and reduced hospital complications, compared to "sliding scale" insulin in general surgery patients with type 2 diabetes.
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
Results from a new study indicate that older hospitalized patients with cancer may have a high risk of being malnourished and experiencing symptoms such as no appetite and nausea, according to findings published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
A quality-improvement project to standardize feeding practices for micro preemies-preterm infants born months before their due date- helped to boost their weight and nearly quadrupled the frequency of lactation consultations ordered in the neonatal intensive care unit, a multidisciplinary team from Children's National Health System finds.
› Verified 3 days ago
Dr. Augustine W Lau, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 2375 S. Ridgeview Drive, Yuma, AZ 85364 Phone: 928-317-2518 Fax: 928-317-1811 | |
Ashvin K Shah, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2110 W 24th St, Yuma, AZ 85364 Phone: 928-344-1891 Fax: 928-726-6306 | |
Aleix M. Bazzi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2095 W. 24th Street, Suite C, Yuma, AZ 85364 Phone: 928-314-1200 Fax: 928-314-1201 | |
Dr. Vernon Barros Chavez, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1210 W 24th St, Suite 2, Yuma, AZ 85364 Phone: 928-726-2500 Fax: 928-726-7853 | |
Dr. Julian J. Nicholas, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-344-2000 | |
Dr. Jeanne Notto Elnadry, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2244 S Avenue A, Suite A, Yuma, AZ 85364 Phone: 928-276-4477 Fax: 928-276-4481 | |
Shahid Mansoor, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 11518 N Frontage Rd Ste A, Yuma, AZ 85367 Phone: 928-342-6500 Fax: 928-342-6863 |